Cardiac Stem Cell/Regeneration therapy

2012 Top 10 Advances in Heart Disease and Stroke Research

Resuscitation, cell regeneration, a new high blood pressure treatment and developments in devices for treating stroke are among the key scientific findings that make up this year's top cardiovascular and stroke research identified by the American...

Baxter Initiates Adult Stem Cell Trial for Chronic Cardiac Ischemia

March 5, 2012 — Baxter International Inc. announced that it initiated a phase III pivotal clinical trial to evaluate the efficacy and safety of adult autologous (individual’s own) CD34+ stem cells to increase exercise capacity in patients with chr...

Cardiobridge, VAD, heart pump, hemodynamic support
Heart Failure 2013 LA Showcases Heart Disease Startup...
The Heart Failure 2013 LA meeting will include a showcase of several startup companies offering innovative new approaches to address heart and cardiovascular...
Cardio3 BioSciences to Begin World's First Phase III...
January 31, 2013 — Belgian biotechnology company Cardio3 BioSciences (C3BS) announced it has received authorization to begin its Congestive Heart failure...
2012 Top 10 Advances in Heart Disease and Stroke Research
2012 Top 10 Advances in Heart Disease and Stroke Research
Resuscitation, cell regeneration, a new high blood pressure treatment and developments in devices for treating stroke are among the key scientific findings...
Cardiac Stem Cells Regeneration Therapy Structural Heart
University of Maryland Study Suggests Neonatal Cardiac Stem...
Researchers at the University of Maryland School of Medicine, who are exploring novel ways to treat serious heart problems in children, have conducted the...

Articles

2012 Top 10 Advances in Heart Disease and Stroke Research
2012 Top 10 Advances in Heart Disease and Stroke Research
Resuscitation, cell regeneration, a new high blood pressure treatment and developments in devices for treating stroke are among the key scientific findings...
Stem Cell Therapy Mildly Effective, But Trial Shows New...
A late-breaking stem cell trial presented at the American College of Cardiology (ACC) Annual Scientific Session showed only minor improvement in heart...
Resurrecting Dead Heart Tissue
For years researchers have experimented with stem cells in attempts to regrow myocardium in patients who suffer permanent tissue damage from myocardial...
Cardiac Regeneration After MI: Role of the Extracellular...
Over the last decade, cardiac stem cell therapy has shown tantalizing but as yet unrealized potential as a treatment for the left-ventricular dysfunction (LVD...

Video Center

view all Videos »

The Radial Access Adoption Report Card
Over the past decade in the United States, there has been growing interest in transradial artery...
11 weeks 14 hours ago
Game-Changing Technologies to Watch in 2013
My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology...
15 weeks 2 days ago
Innovation Exasperation
In a recent LinkedIn Medical Device Group posting, it was noted that DuVal & Associates, P.A....
19 weeks 20 hours ago
View All »
EP lab, Tom De potter, depotter, angiography dose reduction
Less is More — Radiation Exposure Reduction in the EP Lab
This webinar focuses on implementation of different strategies to reduce radiation exposure during interventional electrophysiology (EP) procedures. It offers an overview of the current state-of-the-...
Iterative Reconstruction in CT: Understanding and Implementation
Radiation exposure from multidetector CT (MDCT) has become a pressing public health concern in both lay and medical publications. Implementation of iterative reconstruction offers radiologists the...
Healthcare Reform: What’s the Immediate Impact on Cardiovascular IT?
The recent U.S. Supreme Court ruling upholding the 2010 Affordable Care Act (ACA) may have significant impact on healthcare providers and their cardiovascular departments. While the ruling will...

Comparison Charts

Sorry there is no data available